Benefits and Risks Associated with Low-Dose Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Control Trials and Trial Sequential Analysis
ConclusionThe current study demonstrated that the cardiovascular benefits of low-dose aspirin were equally balanced by major bleeding events. In addition, the potential beneficial effects might be seen in the population ≤ 70 years of age with high cardiovascular risk and no increased risk of bleeding.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Aspirin | Bleeding | Cardiology | Cardiovascular | Clinical Trials | Databases & Libraries | Diabetes | Endocrinology | Gastroenterology | Heart | Heart Attack | Hemorrhagic Stroke | Ischemic Stroke | Statistics | Stroke | Study